Caxton Associates (New York)’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,095
Closed -$479K 496
2021
Q4
$479K Sell
9,095
-14,037
-61% -$751K 0.05% 287
2021
Q3
$1.16M Buy
+23,132
New +$1.2M 0.13% 83

Other funds holding ACA

Caxton Associates (New York)'s ACA Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Arcosa (ACA) in Q1 2022, closing a stake of 9,095 shares — an estimated $479K sold.

Caxton Associates (New York) first reported a position in ACA in Q3 2021 and held it in 2 quarters. The position peaked at $1.16M in Q3 2021. 255 funds tracked by Wall St. Rank hold ACA as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Arcosa position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 9,095 Arcosa shares in Q1 2022, an estimated $479K.
  • Caxton Associates (New York) first reported a position in Arcosa in Q3 2021 and held it in 2 quarters.
  • Caxton Associates (New York)'s Arcosa position peaked at $1.16M in Q3 2021.
  • 255 funds tracked by Wall St. Rank held Arcosa as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.